BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19847424)

  • 1. Multimer technologies for detection and adoptive transfer of antigen-specific T cells.
    Casalegno-Garduño R; Schmitt A; Yao J; Wang X; Xu X; Freund M; Schmitt M
    Cancer Immunol Immunother; 2010 Feb; 59(2):195-202. PubMed ID: 19847424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent detection of circulating minor histocompatibility antigen-specific CD8+ T cells in SCT recipients by combinatorial encoding MHC multimers.
    Broen K; Greupink-Draaisma A; Woestenenk R; Schaap N; Brickner AG; Dolstra H
    PLoS One; 2011; 6(6):e21266. PubMed ID: 21731686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.
    Dolton G; Lissina A; Skowera A; Ladell K; Tungatt K; Jones E; Kronenberg-Versteeg D; Akpovwa H; Pentier JM; Holland CJ; Godkin AJ; Cole DK; Neller MA; Miles JJ; Price DA; Peakman M; Sewell AK
    Clin Exp Immunol; 2014 Jul; 177(1):47-63. PubMed ID: 24673376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer.
    Knabel M; Franz TJ; Schiemann M; Wulf A; Villmow B; Schmidt B; Bernhard H; Wagner H; Busch DH
    Nat Med; 2002 Jun; 8(6):631-7. PubMed ID: 12042816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and Thermal Exchange of Conditional Peptide-MHC I Multimers.
    Luimstra JJ; Franken KLMC; Garstka MA; Drijfhout JW; Neefjes J; Ovaa H
    Curr Protoc Immunol; 2019 Sep; 126(1):e85. PubMed ID: 31483102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers.
    Dolton G; Tungatt K; Lloyd A; Bianchi V; Theaker SM; Trimby A; Holland CJ; Donia M; Godkin AJ; Cole DK; Straten PT; Peakman M; Svane IM; Sewell AK
    Immunology; 2015 Sep; 146(1):11-22. PubMed ID: 26076649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells.
    Koestner W; Hapke M; Herbst J; Klein C; Welte K; Fruehauf J; Flatley A; Vignali DA; Hardtke-Wolenski M; Jaeckel E; Blazar BR; Sauer MG
    Blood; 2011 Jan; 117(3):1030-41. PubMed ID: 21063028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter.
    Maguire O; Chen GL; Hahn TE; Brix L; McCarthy PL; Wallace PK; Minderman H
    Methods; 2017 Jan; 112():75-83. PubMed ID: 27327144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking antigen specific CD4+ T-cells with soluble MHC molecules.
    Gebe JA; Kwok WW
    Methods Mol Med; 2007; 136():39-50. PubMed ID: 17983139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes.
    Tischer S; Kaireit T; Figueiredo C; Hiller O; Maecker-Kolhoff B; Geyeregger R; Immenschuh S; Blasczyk R; Eiz-Vesper B
    Int Immunol; 2012 Sep; 24(9):561-72. PubMed ID: 22740564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells.
    van Loenen MM; de Boer R; van Liempt E; Meij P; Jedema I; Falkenburg JH; Heemskerk MH
    Haematologica; 2014 Apr; 99(4):759-68. PubMed ID: 24334296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes.
    Bouquié R; Bonnin A; Bernardeau K; Khammari A; Dréno B; Jotereau F; Labarrière N; Lang F
    Cancer Immunol Immunother; 2009 Apr; 58(4):553-66. PubMed ID: 18751701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.
    Warren EH; Fujii N; Akatsuka Y; Chaney CN; Mito JK; Loeb KR; Gooley TA; Brown ML; Koo KK; Rosinski KV; Ogawa S; Matsubara A; Appelbaum FR; Riddell SR
    Blood; 2010 May; 115(19):3869-78. PubMed ID: 20071660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells.
    Pittet MJ; Rubio-Godoy V; Bioley G; Guillaume P; Batard P; Speiser D; Luescher I; Cerottini JC; Romero P; Zippelius A
    J Immunol; 2003 Aug; 171(4):1844-9. PubMed ID: 12902485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of CD8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers.
    Savage P; Millrain M; Dimakou S; Stebbing J; Dyson J
    Tumour Biol; 2007; 28(2):70-6. PubMed ID: 17264539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells.
    Batard P; Peterson DA; Devêvre E; Guillaume P; Cerottini JC; Rimoldi D; Speiser DE; Winther L; Romero P
    J Immunol Methods; 2006 Mar; 310(1-2):136-48. PubMed ID: 16516226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responses.
    van Buuren MM; Dijkgraaf FE; Linnemann C; Toebes M; Chang CX; Mok JY; Nguyen M; van Esch WJ; Kvistborg P; Grotenbreg GM; Schumacher TN
    J Immunol; 2014 Jan; 192(2):641-8. PubMed ID: 24342804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection of leukemic cells requires antigen-specific T cells with high functional avidity.
    Vincent K; Hardy MP; Trofimov A; Laumont CM; Sriranganadane D; Hadj-Mimoune S; Salem Fourati I; Soudeyns H; Thibault P; Perreault C
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):37-45. PubMed ID: 24161924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells.
    Hadrup SR; Maurer D; Laske K; Frøsig TM; Andersen SR; Britten CM; van der Burg SH; Walter S; Gouttefangeas C
    Cytometry A; 2015 Jan; 87(1):37-48. PubMed ID: 25297339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.